TNF-α inhibitors in systemic vasculitides and connective tissue diseases
- 31 January 2005
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 4 (1) , 28-34
- https://doi.org/10.1016/j.autrev.2004.06.001
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Molecular Mimicry in Multiple SclerosisNew England Journal of Medicine, 2003
- Therapy of autoimmune diseases: clinical trials and new biologicsCurrent Opinion in Immunology, 2002
- TNF neutralization in MSNeurology, 1999
- Renal expression of IL-6 and TNFα genes in lupus nephritisLupus, 1998
- TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelinationNature Medicine, 1998
- Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2Neurology, 1996
- Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.Proceedings of the National Academy of Sciences, 1995
- Multiple sclerosis: TNF revisited, with promiseNature Medicine, 1995
- Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteinsEuropean Journal of Immunology, 1994
- Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple SclerosisNew England Journal of Medicine, 1991